The Rising Era of “Immunoporosis”: Role of Immune System in the Pathophysiology of Osteoporosis
Top Cited Papers
Open Access
- 1 March 2022
- journal article
- review article
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 15, 1667-1698
Abstract
Discoveries in the last few years have emphasized the existence of an enormous breadth of communication between bone and the immune system in maintaining skeletal homeostasis. Originally, the discovery of various factors was assigned to the immune system viz. interleukin (IL)-6, IL-10, IL-17, tumor necrosis factor (TNF)-α, receptor activator of nuclear factor kappa B ligand (RANKL), nuclear factor of activated T cells (NFATc1), etc., but now these factors have also been shown to have a significant impact on osteoblasts (OBs) and osteoclasts (OCs) biology. These discoveries led to an alteration in the approach for the treatment of several bone pathologies including osteoporosis. Osteoporosis is an inflammatory bone anomaly affecting more than 500 million people globally. In 2018, to highlight the importance of the immune system in the pathophysiology of osteoporosis, our group coined the term “immunoporosis”. In the present review, we exhaustively revisit the characteristics, mechanism of action, and function of both innate and adaptive immune cells with the goal of understanding the potential of immune cells in osteoporosis. We also highlight the Immunoporotic role of gut microbiota (GM) for the treatment and management of osteoporosis. Importantly, we further discuss whether an immune cell-based strategy to treat and manage osteoporosis is feasible and relevant in clinical settings. Graphical Abstract:Keywords
This publication has 180 references indexed in Scilit:
- Thymus-derived regulatory T cells contribute to tolerance to commensal microbiotaNature, 2013
- Model‐driven multi‐omic data analysis elucidates metabolic immunomodulators of macrophage activationMolecular Systems Biology, 2012
- IgE and mast cells in allergic diseaseNature Medicine, 2012
- Peripheral Blood Monocyte-expressed ANXA2 Gene is Involved in Pathogenesis of Osteoporosis in HumansMolecular & Cellular Proteomics, 2011
- Transforming Growth Factor-β1 (TGF-β1) Induces Human Osteoclast Apoptosis by Up-regulating BimJournal of Biological Chemistry, 2009
- Natural killer cells trigger osteoclastogenesis and bone destruction in arthritisProceedings of the National Academy of Sciences, 2009
- A role for γ/δ T cells in a mouse model of fracture healingArthritis & Rheumatism, 2009
- A Regulatory B Cell Subset with a Unique CD1dhiCD5+ Phenotype Controls T Cell-Dependent Inflammatory ResponsesImmunity, 2008
- Functions of RANKL/RANK/OPG in bone modeling and remodelingArchives of Biochemistry and Biophysics, 2008
- Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destructionJournal of Experimental Medicine, 2006